Programma cfDNA Dag 2022

Presentaties 2022

  • Current and future perspectives of liquid biopsies in genomics-driven oncology (Ellen Heitzer, Graz, Austria)
  • Leveraging cfDNA biology and fragmentation to boost liquid biopsy (Florent Mouliere, AmsterdamUMC)
  • Cancer of Unknown Primary (CUP) diagnosis using cfRRBS-methylation profiling (Jilke De Wilde, VIB-UGent, Belgium)
  • ctDNA monitoring by methylated cfDNA sequencing (cfMeD-seq) of LpnPI digested fragments (Saskia Wilting, ErasmusMC)
  • Dynamic changes of ctDNA predict clinical outcome in NSCLC patients treated with immune checkpoint inhibitors (Harry Groen, UMCG)
  • Elucidating Prostate Cancer Behaviour During Treatment using ctDNA (Niven Mehra, RadboudMC)
  • Diagnosing leptomeningeal metastases in cancer patients: should we use cells or ctDNA? (Dieta Brandsma en Mirjam Boelens, NKI)
  • COIN-session